-
Je něco špatně v tomto záznamu ?
Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome
J. Šilhavý, P. Mlejnek, M. Šimáková, H. Malínská, I. Marková, M. Hüttl, D. Miklánková, L. Kazdová, M. Vrbacký, A. Pecinová, T. Mráček, M. Pravenec
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
36837811
DOI
10.3390/metabo13020192
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Recently, red beetroot has attracted attention as a health-promoting functional food. Studies have shown that beetroot administration can reduce blood pressure and ameliorate parameters of glucose and lipid metabolism; however, mechanisms underlying these beneficial effects of beetroot are not yet fully understood. In the current study, we analysed the effects of beetroot on parameters of glucose and lipid metabolism in two models of metabolic syndrome: (i) transgenic spontaneously hypertensive rats expressing human C-reactive protein (SHR-CRP rats), and (ii) hereditary hypertriglyceridemic (HHTg) rats. Treatment with beetroot juice for 4 weeks was, in both models, associated with amelioration of oxidative stress, reduced circulating lipids, smaller visceral fat depots, and lower ectopic fat accumulation in the liver compared to the respective untreated controls. On the other hand, beetroot treatment had no significant effects on the sensitivity of the muscle and adipose tissue to insulin action in either model. Analyses of hepatic proteome revealed significantly deregulated proteins involved in glycerophospholipid metabolism, mTOR signalling, inflammation, and cytoskeleton rearrangement.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003070
- 003
- CZ-PrNML
- 005
- 20230421100046.0
- 007
- ta
- 008
- 230413s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/metabo13020192 $2 doi
- 035 __
- $a (PubMed)36837811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Šilhavý, Jan $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
- 245 10
- $a Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome / $c J. Šilhavý, P. Mlejnek, M. Šimáková, H. Malínská, I. Marková, M. Hüttl, D. Miklánková, L. Kazdová, M. Vrbacký, A. Pecinová, T. Mráček, M. Pravenec
- 520 9_
- $a Recently, red beetroot has attracted attention as a health-promoting functional food. Studies have shown that beetroot administration can reduce blood pressure and ameliorate parameters of glucose and lipid metabolism; however, mechanisms underlying these beneficial effects of beetroot are not yet fully understood. In the current study, we analysed the effects of beetroot on parameters of glucose and lipid metabolism in two models of metabolic syndrome: (i) transgenic spontaneously hypertensive rats expressing human C-reactive protein (SHR-CRP rats), and (ii) hereditary hypertriglyceridemic (HHTg) rats. Treatment with beetroot juice for 4 weeks was, in both models, associated with amelioration of oxidative stress, reduced circulating lipids, smaller visceral fat depots, and lower ectopic fat accumulation in the liver compared to the respective untreated controls. On the other hand, beetroot treatment had no significant effects on the sensitivity of the muscle and adipose tissue to insulin action in either model. Analyses of hepatic proteome revealed significantly deregulated proteins involved in glycerophospholipid metabolism, mTOR signalling, inflammation, and cytoskeleton rearrangement.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mlejnek, Petr $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
- 700 1_
- $a Šimáková, Miroslava $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
- 700 1_
- $a Malínská, Hana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000290763399
- 700 1_
- $a Marková, Irena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000243317636
- 700 1_
- $a Hüttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
- 700 1_
- $a Miklánková, Denisa $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
- 700 1_
- $a Kazdová, Ludmila $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000305630186
- 700 1_
- $a Vrbacký, Marek $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic
- 700 1_
- $a Pecinová, Alena $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic $1 https://orcid.org/0000000202047502 $7 xx0167913
- 700 1_
- $a Mráček, Tomáš $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic $1 https://orcid.org/0000000294920718 $7 xx0122128
- 700 1_
- $a Pravenec, Michal $u Institute of Physiology, Czech Academy of Sciences, 14200 Prague, Czech Republic $1 https://orcid.org/0000000191975871 $7 nlk20030127611
- 773 0_
- $w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 13, č. 2 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36837811 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20230421100038 $b ABA008
- 999 __
- $a ok $b bmc $g 1922762 $s 1189277
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 13 $c 2 $e 20230128 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
- LZP __
- $a Pubmed-20230413